Evidence map›Paper›PMID 35618619›Full record

ArticleJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy2022

A case of Bacillus subtilis var. natto bacteremia caused by ingestion of natto during COVID-19 treatment in a maintenance hemodialysis patient with multiple myeloma.

Ai Kato, Ayumi Yoshifuji, Kohji Komori, Kotaro Aoki, Daisuke Taniyama, Motoaki Komatsu, Kentaro Fujii, Kuniko Yamada, Yoshikazu Ishii, Takahide Kikuchi and 1 more

Open access · greenAbstract readCase Reports
In one paragraph

Article in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The Majority ofOpen forum infectious diseases · 2025
    Article
  5. Article
  6. Immobilization of Silver Nanoparticles with Defensive Gum ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Article
  9. A case of community-acquired pneumonia caused byRespirology case reports · 2024
    Article
  10. Review
  11. A rare case ofIDCases · 2024
    Article
  12. Article
  13. Bacterial Meningitis Caused by Bacillus subtilis var. natto.Internal medicine (Tokyo, Japan) · 2023
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ai KatoDivision of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
Ayumi YoshifujiDivision of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan. Electronic address: ayutsuranaide@hotmail.com.
Kohji KomoriDepartment of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan.
Kotaro AokiDepartment of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan.
Daisuke TaniyamaDivision of General Internal Medicine and Infectious Diseases, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
Motoaki KomatsuDivision of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
Kentaro FujiiDivision of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
Kuniko YamadaClinical Laboratory, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
Yoshikazu IshiiDepartment of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan.
Takahide KikuchiDivision of Hematology, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
Munekazu RyuzakiDivision of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
Saiseikai Central Hospital · JPToho University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 70-year-old woman, who started on hemodialysis 7 months before for end-stage renal disease due to diabetic nephropathy and was diagnosed with symptomatic multiple myeloma 1 month before, was admitted to our hospital with critical coronavirus disease 2019 and treated with long-term immunosuppressive therapy such as steroids and tocilizumab. During treatment, Bacillus subtilis was detected in the blood cultures. We could not exclude the association of natto (fermented soybeans) with B. subtilis var. natto, which the patient had been eating every day from 8 days after admission. She was prohibited from eating natto and treated with vancomycin. Later, B. subtilis detected in the blood culture was identified as B. subtilis var. natto, which was identical with those contained in the natto that the patient consumed daily using a next-generation sequencer. Gut dysbiosis due to old age, malignant tumor, diabetes mellitus, end-stage renal disease, and intestinal inflammation caused by severe acute respiratory syndrome coronavirus 2 increased intestinal permeability and the risk of bacterial translocation, causing B. subtilis var. natto bacteremia. Therefore, careful consideration might be given to the intake of fermented foods containing live bacteria in patients with severe immunocompromised conditions.

Indexed as

BacteremiaCOVID-19COVID-19 Drug TreatmentKidney Failure, ChronicMultiple MyelomaSoy FoodsAgedBacillus subtilisEatingFemaleHumansRenal DialysisBacillus subtilis var. natto bacteremiaCOVID-19Hematological malignancyHemodialysis

Identifiers

PMID35618619
PMCPMC9691286
OpenAlexW4281390554

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.